These pathological roles of Th17 cells in viral myocarditis make them a potential therapeutic target, and the addition of Th17-inhibiting factors such as IL-27, IL-35, IL-37, and progranulin has already been shown to reduce myocarditis in mouse models [133,134,135,136]. This evidence concerns the gene IL37 and viral myocarditis.